OG713399
JP 2021089220-A/11: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER.
672
PRT
Mus musculus
OG713396
JP 2021089220-A/8: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER.
11
PRT
synthetic construct
OG714739
WO 2021112225-A/12: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER.
672
PRT
Mus musculus
OG713400
JP 2021089220-A/12: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER.
672
PRT
Mus musculus
OG714734
WO 2021112225-A/7: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER.
11
PRT
synthetic construct
OG714735
WO 2021112225-A/8: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER.
11
PRT
synthetic construct
OG713395
JP 2021089220-A/7: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER.
11
PRT
synthetic construct
OG714738
WO 2021112225-A/11: METHOD FOR DIAGNOSING CANCER, COMPOSITION FOR DIAGNOSING CANCER, KIT DIAGNOSING CANCER, METHOD OF EVALUATING CONDITION OF CANCER, AND DRUG FOR PREVENTING AND/OR TREATING CANCER.
672
PRT
Mus musculus
HZ455490
JP 2015213503-A/8: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR.
20
DNA
synthetic construct
HZ455498
JP 2015213503-A/16: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR.
55
RNA
synthetic construct
BD162197
JP 2002173500-A/4: Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer.
30
DNA
synthetic construct
DM115373
WO 2008156172-A/45: Double-stranded nucleic acid molecules suitable for prevention or treatment of uterine cancer, breast cancer, or bladder cancer, Agent for inhibiting cancer cell proliferation, and Medicine.
21
DNA
synthetic construct
HZ455489
JP 2015213503-A/7: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR.
20
DNA
synthetic construct
HZ455497
JP 2015213503-A/15: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR.
55
RNA
synthetic construct
BD162200
JP 2002173500-A/7: Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer.
24
DNA
synthetic construct
DM115372
WO 2008156172-A/44: Double-stranded nucleic acid molecules suitable for prevention or treatment of uterine cancer, breast cancer, or bladder cancer, Agent for inhibiting cancer cell proliferation, and Medicine.
21
DNA
synthetic construct
HZ455484
JP 2015213503-A/2: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR.
21
RNA
synthetic construct
HZ455492
JP 2015213503-A/10: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR.
21
DNA
synthetic construct
BD827399
JP 2005506514-A/9: METHODS OF DIAGNOSING COLORECTAL CANCER AND/OR BREAST CANCER, COMPOSITIONS, AND METHODS OF SCREENING FOR COLORECTAL CANCER AND/OR BREAST CANCER MODULATORS.
187
PRT
Mus musculus
BD827402
JP 2005506514-A/12: METHODS OF DIAGNOSING COLORECTAL CANCER AND/OR BREAST CANCER, COMPOSITIONS, AND METHODS OF SCREENING FOR COLORECTAL CANCER AND/OR BREAST CANCER MODULATORS.
5
PRT
unidentified
OG148742
JP 2019511469-A/4: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS.
720
DNA
synthetic construct
DD183398
JP 2005192484-A/29: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA.
20
DNA
synthetic construct
DD183406
JP 2005192484-A/37: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA.
20
DNA
synthetic construct
DD183414
JP 2005192484-A/45: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA.
20
DNA
synthetic construct
DM373411
JP 2009168526-A/5: Serum tumor marker for detection of digestive cancer, detection kit for digestive cancer, and detection method for digestive cancer.
15
DNA
synthetic construct
LG686932
KR 1020180110090-A/6: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS USING ANTIBODY TO ADVANCED GLYCATION END PRODUCTS (AGE).
415
PRT
Equus caballus
LG686936
KR 1020180110090-A/10: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS USING ANTIBODY TO ADVANCED GLYCATION END PRODUCTS (AGE).
96
PRT
Camelus dromedarius
LG686940
KR 1020180110090-A/18: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS USING ANTIBODY TO ADVANCED GLYCATION END PRODUCTS (AGE).
239
PRT
synthetic construct
LG686944
KR 1020180110090-A/22: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS USING ANTIBODY TO ADVANCED GLYCATION END PRODUCTS (AGE).
326
PRT
synthetic construct
LG686948
KR 1020180110090-A/26: METHOD AND COMPOSITION FOR TREATING CANCER, KILLING METASTATIC CANCER CELLS AND PREVENTING CANCER METASTASIS USING ANTIBODY TO ADVANCED GLYCATION END PRODUCTS (AGE).
17
PRT
synthetic construct